Navigation Links
The 10 biggest events shaping biotech in 2006

As we are still in January, it is a good time to look back at 2006 to identify some of the key events that shaped the biotech industry and its development, particularly in the Midwest.

Here's my list, in order of importance: biofuels, stem cells, BIO 2006 in Chicago, the reshaping and resurgence of Abbott Labs, biogenerics in the U.S., the internationalizati......

Full article >>> announcements by both GE and Siemens were symbolic of this convergence, with the announcement of GE acquiring Abbott's in vitro diagnostics business for over $8 billion, and Siemens' acquisition of Bayer's diagnostics business and Diagnostics Products Corp. (in July, 2006) for 5.7 billion (about $7.35 billion), which sent shock waves through the industry.
<......

Full article >>> eported throughout the year, the growth of biotech in countries such as Switzerland, China, Israel, Korea, and Japan, is staggering, and I was personally able to witness this through my trips.

Nanotechnology financing

I wrote about this earlier, as at least four Midwest nanotech companies raised over $110 million in venture capital financing in 2006, including: Cipla, Dr. Reddy's, Ranbaxy, Sun Pharma, etc. - took advantage of fire sales by Big Pharma in selling off key assets in Europe (as a result of consolidation). Indian pharma is following the lead of Israeli generic leader Teva Pharmaceutica......

Full article >>> n equity piece of Boston Scientific - all in the same deal. Abbott topped off the year with another aggressive acquisition of Kos Pharmaceuticals, a cardiovascular drug specialty pharma company, and almost in the same breath, disposal of its in vitro diagnostics business.

No, Abbott has not exited the diag......

Full article >>> of many major diseases, many states took legislative initiatives to accelerate the finding and development of new stem cell-based research and therapies. Not bad considering that Wisconsin was the forerunner of much of this research, and holds a number of key patents. The promise of stem cell-based therapy is still early but exciting, and it may change the course of therapy as we know it.

......

Full article >>> llion to net farm income by 2025.

For those of you who scoff at this, when I visited Brazil during 2006, I personally witnessed how this country had harnessed biotechnology with their sugar cane crop to become self sufficient in gas. Even President Bush jumped on the biofuels bandwagon in his 2007 State of the Union address when he establ......

Full article >>> org">Illinois Biotechnology Industry Organization. He can be reached at rosenmichaels@aol.com.

The opinions expressed herein or statements made in the above column are solely those of the author, and do not necessarily reflect the views of Wisconsin Technology Network, LLC.

WTN accepts no legal liability or responsibility for any cla......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 01/29/07


Related biology technology :

1. Privacy, trust still the biggest barriers to electronic record sharing
2. Just one nanosecond: Clocking events at the nanoscale
3. How to get through tech-sector networking events alive
4. Furious pace of Midwest biotech events marks progress
5. Dispelling the top five myths about attending networking events
6. The state of global biotech: An Ernst & Young perspective
7. Olympics of biotechnology has international flavor
8. Getting noticed in Genetown: Wisconsin biotech on display
9. Madison biotech NimbleGen files for IPO; one of states best-funded firms
10. Wisconsin biotech firm receives $107K NIH grant
11. Manufacturing partnership will move into biotech and biomedical spaces
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... ... February 24, 2017 , ... A study recently ... in an ambulatory surgery center (ASC) with satisfactory clinical and patient-reported outcomes, when ... studies. , Jake Lubinski, president of AxioMed, commented on the recent publication, ...
(Date:2/24/2017)... , Feb. 24, 2017 Symic Bio, a ... a new category of therapeutics, announced today the completion ... in peripheral artery disease. The trial will evaluate the ... therapeutic, in the reduction of restenosis following angioplasty. ... development milestone for SB-030," said Nathan Bachtell , ...
(Date:2/24/2017)... Feb. 24, 2017  VWR Corporation (NASDAQ: VWR), the leading ... and production customers, today reported its financial results for the ... Highlights: 4Q16 record quarterly net ... on an organic basis. 4Q16 ... organic basis, while the Americas net sales increased 2.5%, or ...
(Date:2/23/2017)... , Feb. 23, 2017 /PRNewswire/ - The Fight Against ... Cancer Research (OICR) are pleased to report that Fusion ... financing, with Johnson & Johnson Innovation – JJDC, Inc. ... venture groups HealthCap, TPG Biotechnology Partners, and Genesys Capital, ... ...
Breaking Biology Technology:
(Date:2/8/2017)... YORK , Feb. 7, 2017 Report Highlights ... The ... should reach $11.4 billion by 2021, growing at a compound ... Includes - An overview of the global markets for synthetic ... 2015, estimates for 2016, and projections of compound annual growth ...
(Date:2/7/2017)... Feb. 7, 2017   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... its innovative, highly flexible and award winning eClinical solution, ... iMedNet is a proven Software-as-a-Service (SaaS) clinical ... Capture (EDC), but also delivers an entire suite of ...
(Date:2/6/2017)... , Feb. 6, 2017 According to ... are driving border authorities to continue to embrace ... there are 2143 Automated Border Control (ABC) eGates ... deployed at more than 163 ports of entry ... to 2016 achieving a combined CAGR of 37%. ...
Breaking Biology News(10 mins):